The drug concentration of CAP-methazolamide eye drop solutions was 400~500μg/ml, pH was 6.8~7.5.
钙纳米醋甲唑胺滴眼液的药物浓度范围400~500μg/ml,pH 6.8~7.5。
参考来源 - 钙纳米醋甲唑胺滴眼液的研制和临床前研究·2,447,543篇论文数据,部分数据来源于NoteExpress
Objective To study the therapeutic effect of methazolamide on glaucoma.
目的探讨醋甲唑胺对青光眼的治疗价值。
Carbonic anhydrase inhibitors (CAIs) were first used to lower intraocular pressure (IOP) in glaucoma in 1954, with the introduction of acetazolamide, methazolamide and diclofenamide were subsequently.
乙酰唑胺、醋甲唑胺、双氯非那胺等碳酸酐酶抑制剂自1954年起就被应用于青光眼的降眼压治疗。
应用推荐